Dexcom INC Form 4 insider transactions

Teri L Lawver, EVP and Chief Commercial Officer of DexCom Inc., reports acquiring 26,053 shares of common stock through a grant of restricted stock units.

Executive Vice President of Strategy and Corporate Development at Dexcom, Matthew Vincent Dolan, reports the acquisition of 21,711 shares of restricted stock units.

EVP and Chief Legal Officer of Dexcom, Michael Jon Brown, reports the acquisition of 21,711 restricted stock units.